ELII: Advanced Development of a Multivalent Filovirus (Ebola/Marburg) Hemorrhagic Fever Vaccine

Project: Other project

StatusFinished
Effective start/end date4/22/136/30/15

Funding

  • Crucell Holland B.V.: $269,426.00